BlossomHill Therapeutics (BLSM) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 5 30 sessions, August 7, 2026 to September 18, 2026
- Largest daily move
- +18.4% close of September 16, 2026
Company Description
BlossomHill Therapeutics (NASDAQ: BLSM) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $818.1M.
BLSM has gained 59.9% over the past month. The last closing price was $25.74.
This page collects what Stock Titan holds for BLSM, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
BlossomHill Therapeutics (BLSM) closed at $25.74 on September 18, 2026. Over the past month, the price has gained 59.9%.
BLSM Metrics & Rankings
Price returns through September 18, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
BlossomHill Therapeutics has 6 recent news articles, with the latest published 3 days ago. Of the recent coverage, 3 articles coincided with positive price movement and 2 with negative movement. Key topics include earnings, clinical trial, IPO, offering. View all BLSM news →
SEC Filings
BlossomHill Therapeutics has filed 10 recent SEC filings, including 3 Form 4, 2 Form 8-K, 2 Form SCHEDULE 13D, 2 Form SCHEDULE 13G. The most recent filing was submitted on September 18, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all BLSM SEC filings →
Insider Radar
Insider buying activity at BlossomHill Therapeutics over the past 90 days may reflect management confidence in the company's direction. Institutional investors and analysts often monitor insider purchases as a potential bullish indicator for the stock.
Financial Highlights
Upcoming Events
Global Phase 2 Trial
BlossomHill Therapeutics has 1 upcoming scheduled event. The next event, "Global Phase 2 Trial", is scheduled for January 1, 2027 (in 101 days). Investors can track these dates to stay informed about potential catalysts that may affect the BLSM stock price.
Short Interest History
Short interest in BlossomHill Therapeutics (BLSM) currently stands at 110.8 thousand shares, down 1.0% from the previous reporting period, representing 1.4% of the float. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for BlossomHill Therapeutics (BLSM) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.
BLSM Company Profile & Sector Positioning
BlossomHill Therapeutics (BLSM) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the NASDAQ.